Ozone Therapy – An Unmatched Approach for Near Universal Prevention and Treatment
Main Article Content
Abstract
Ozone therapy (OT) has been published for decades as a versatile therapy for a wide variety of conditions. The purpose of this report is to bring forward known biochemistry which supports clinical observations of its utility.
Extraordinarily safe, ozone can be administered locally or systemically, or both, to any part of the body except lungs. OT improves oxygen delivery and uptake by a variety of mechanisms. It safely modulates inflammation by reducing inflammatory enzymes and raising and raising anti-inflammatory cytokines and mediators. OT activates the critical Nrf2 transcription pathway, which functions include crucial anti-oxidant enzymes production, DNA repair, mitochondrial protection and biogenesis, protein folding, anti-ageing, and more. OT preconditioning protects the organism against chemical and infection stressors, and reperfusion injury. It has adjunct uses in the management of cancer, and may slow ageing processes and degenerative disease, particularly skeletal by local injection. OT has significant utility in dentistry for prevention, treatment, repair and regeneration, including articular cartilage. Because ozone is not patentable for profit, and would clearly challenge the current medical paradigm of disease maintenance drug therapy, it remains a “pariah” to drug promoting regulatory authorities, while it could address the urgent universal need for safe, effective, and non-resistance promoting approaches to infectious diseases and “superbugs”, including generally untreatable viral disease. OT suffers from the “tomato effect” in that mainstream medicine shuns it, even where conventional medicine has dangerous approaches or no answers at all.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Bocci V. How a calculated oxidative stress can yield multiple therapeutic effects. Free Radic. Res. 2012;46:1068–1075. doi: 10.3109/10715762.2 012.693609. [PubMed] [CrossRef] [Google Scholar] [Ref list]
3. Mattson MP. Hormesis defined. Ageing Res Rev. 2008 Jan;7(1):1-7. doi: 10.1016/j.arr.2007.0 8.007. Epub 2007 Dec 5. PMID: 18162444; PMCID: PMC2248601.
4. de Sire A, Marotta N, Ferrillo M, Agostini F, Sconza C, Lippi L, Respizzi S, Giudice A, Invernizzi M, Ammendolia A. Oxygen-OT for Reducing Pro-Inflammatory Cytokines Serum Levels in Musculoskeletal and Temporomandibular Disorders: A Comprehensive Review. Int J Mol Sci. 2022 Feb 25;23(5):2528. doi: 10.3390/ijms23052528. PMID: 35269681; PMCID: PMC8910188.
5. Vaillant JD, Fraga A, Díaz MT, Mallok A, Viebahn-Hänsler R, Fahmy Z, Barberá A, Delgado L, Menéndez S, Fernández OS. Ozone oxidative postconditioning ameliorates joint damage and decreases pro-inflammatory cytokine levels and oxidative stress in PG/PS-induced arthritis in rats. Eur J Pharmacol. 2013 Aug 15;714(1-3):318-24. doi: 10.1016/j.ejphar.2013.07.034. Epub 2013 Jul 31. PMID: 23911887.
6. Xie TY, Yan W, Lou J, Chen XY. Effect of ozone on vascular endothelial growth factor (VEGF) and related inflammatory cytokines in rats with diabetic retinopathy. Genet Mol Res. 2016 May 13; 15(2). doi: 10.4238/gmr.15027558. PMID: 27323014.
7. Bilge, A., Tüysüz, M., Öztürk, Ö., Adali, Y., EROĞLU, H., Makav, M., Atila Uslu, G.Ö.Z.D.E. and Tiskaoğlu, R., 2019. The investigation of the effect of OT on gout iexperimental rat models Deneysel olarak gut oluşturulmuş ratlarda ozon terapinin etkisi. Kafkas Universitesi Veteriner Fakultesi Dergisi, 25(2). [Google Scholar]
8. Bocci V. Ozone: a new medical drug. Dordrecht: Springer; 2005. [Google Scholar]
9. Zamora ZB, Borrego A, López OY, Delgado R, González R, Menéndez S, Hernández F, Schulz S. Effects of ozone oxidative preconditioning on TNF-alpha release and antioxidant-prooxidant intracellular balance in mice during endotoxic shock. Mediators Inflamm. 2005 Feb 24;2005(1): 16-22. doi: 10.1155/MI.2005.16. PMID: 15770062; PMCID: PMC1482874.
11. Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009 Dec;1(6):a001651. doi: 10.1101/cshpers pect.a001651. Epub 2009 Oct 7. PMID: 20457564; PMCID: PMC2882124.
12. Liu T, Zhang L, Joo D, Sun SC. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017; 2:17023–. doi: 10.1038/sigtrans.2017.23. Epub 2017 Jul 14. PMID: 29158945; PMCID: PMC5661633.
13. Sumihito Togi, Misa Togi, Satoshi Nagashima, Yuichi Kitai, Ryuta Muromoto, Jun-ichi Kashiwakura, Toshiaki Miura, Tadashi Matsuda, Implication of NF-κB Activation on Ozone-Induced HO-1 Activation, BPB Reports, 2021, Volume 4, Issue 2,
14. Rowen RJ. Remission of aggressive autoimmune disease (dermatomyositis) with removal of infective jaw pathology and OT: review and case report. Auto Immun Highlights. 2018 Jun 30;9(1):7. doi: 10.1007/s13317-018-0107-z. PMID: 29959639; PMCID: PMC6026108.
15. Tartari APS, Moreira FF, Pereira MCDS, Carraro E, Cidral-Filho FJ, Salgado AI, Kerppers II. Anti-inflammatory Effect of OT in an Experimental Model of Rheumatoid Arthritis. Inflammation. 2020 Jun;43(3):985-993. doi: 10.1007/s10753-020-01184-2. PMID: 32382842.
16. Bains A, Kohrman S, Punko D, Fricchione G. A Link Between Inflammatory Mechanisms and Fibromyalgia. Adv Exp Med Biol. 2023;1411:357-378. doi: 10.1007/978-981-19-7376-5_16. PMID: 36949318.
17. Tirelli U, Cirrito C, Pavanello M, Piasentin C, Lleshi A, Taibi R. OT in 65 patients with fibromyalgia: an effective therapy. Eur Rev Med Pharmacol Sci. 2019 Feb;23(4):1786-1788. doi: 10.26355/eurrev_2 01902_17141. PMID: 30840304.
18. de Sire A, Marotta N, Ferrillo M, Agostini F, Sconza C, Lippi L, Respizzi S, Giudice A, Invernizzi M, Ammendolia A. Oxygen-OT for Reducing Pro-Inflammatory Cytokines Serum Levels in Musculoskeletal and Temporomandibular Disorders: A Comprehensive Review. Int J Mol Sci. 2022 Feb 25;23(5):2528. doi: 10.3390/ijms23052528. PMID: 35269681; PMCID: PMC8910188.
19. Hashemi M., Khameneh S.M.H., Dadkhah P., Mohajerani S.A. Effect of Intraarticular injection of ozone on inflammatory cytokines in knee osteoarthritis. J. Cell. Mol. Anesth. 2017;2:37–42.
20. Yasir M, Goyal A, Sonthalia S. Corticosteroid Adverse Effects. [Updated 2023 Jul 3]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK531462/
21. Cuccio, G., & Franzini, M. (2016). Oxygen-OT in the treatment of adipose tissue diseases. OT, 1(2), 25–33. https://doi.org/10.4081/ozone.2016.6270
22. Rowen RJ, Robins H. OT for Complex Regional Pain Syndrome: Review and Case Report. Curr Pain Headache Rep. 2019 May 6;23(6):41. doi: 10.1007/s11916-019-0776-y. PMID: 31062104; PMCID: PMC6502773.
23. Galiè M, Covi V, Tabaracci G, Malatesta M. The Role of Nrf2 in the Antioxidant Cellular Response to Medical Ozone Exposure. Int J Mol Sci. 2019 Aug 17;20(16):4009. doi: 10.3390/ijms20164009. PMID: 31426459; PMCID: PMC6720777.
24. Ma Q. Role of Nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol. 2013;53: 401-26. doi: 10.1146/annurev-pharmtox-011112-140320. PMID: 23294312; PMCID: PMC4680839.
25. Ngo V, Duennwald ML. Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease. Antioxidants (Basel). 2022 Nov 27;11(12):2345. doi: 10.3390/antiox11 122345. PMID: 36552553; PMCID: PMC9774434.
26. Dodson M, Shakya A, Anandhan A, Chen J, Garcia JGN, Zhang DD. NRF2 and Diabetes: The Good, the Bad, and the Complex. Diabetes. 2022 Dec 1;71(12):2463-2476. doi: 10.2337/db22-0623. PMID: 36409792; PMCID: PMC9750950.
27. Delgado-Roche L, Riera-Romo M, Mesta F, Hernández-Matos Y, Barrios JM, Martínez-Sánchez G, Al-Dalaien SM. Medical ozone promotes Nrf2 phosphorylation reducing oxidative stress and pro-inflammatory cytokines in multiple sclerosis patients. Eur J Pharmacol. 2017 Sep 15;811:148-154. doi: 10.1016/j.ejphar.2017.06.017. Epub 2017 Jun 13. PMID: 28623000.Nrf
28. Shan Y., Schoenfeld R.A., Hayashi G., Napoli E., Akiyama T., Iodi Carstens M., Carstens E.E., Pook M.A., Cortopassi G.A. Frataxin deficiency leads to defects in expression of antioxidants and Nrf2 expression in dorsal root ganglia of the Friedreich’s ataxia YG8R mouse model. Antioxid.Redox Signal. 2013;19:1481–1493.[PMC free article] [PubMed] [Google Scholar][Ref list]
29. Holmstrom K.M., Kostov R.V., Dinkova-Kostova A.T. The multifaceted role of Nrf2 in mitochondrial function. Curr. Opin. Toxicol. 2016; 1:80–91. [PMC free article] [PubMed] [Google Scholar] [Ref list]
30. Galiè M, Covi V, Tabaracci G, Malatesta M. The Role of Nrf2 in the Antioxidant Cellular Response to Medical Ozone Exposure. Int J Mol Sci. 2019 Aug 17;20(16):4009. doi: 10.3390/ijms2 0164009. PMID: 31426459; PMCID: PMC6720777.
31. Ding S, Duanmu X, Xu L, Zhu L, Wu Z. Ozone pretreatment alleviates ischemiareperfusion injury-induced myocardial ferroptosis by activating the Nrf2/Slc7a11/Gpx4 axis. Biomed Pharmacother. 2023 Sep;165:115185. doi: 10.1016/j.biopha.202 3.115185. Epub 2023 Jul 22. PMID: 37487441.
32. Bocci V, Aldinucci C, Mosci F, Carraro F, Valacchi G. Ozonation of human blood induces a remarkable upregulation of heme oxygenase-1 and heat stress protein-70. Mediators Inflamm. 2007; 2007:26785. doi: 10.1155/2007/26785. PMID: 182 74635; PMCID: PMC2233812.
33. Galiè M, Covi V, Tabaracci G, Malatesta M. The Role of Nrf2 in the Antioxidant Cellular Response to Medical Ozone Exposure. Int J Mol Sci. 2019 Aug 17;20(16):4009. doi: 10.3390/ijms20 164009. PMID: 31426459; PMCID: PMC6720777.
34. Grosser N, Abate A, Oberle S, Vreman HJ, Dennery PA, Becker JC, Pohle T, Seidman DS, Schröder H. Heme oxygenase-1 induction may explain the antioxidant profile of aspirin. Biochem Biophys Res Commun. 2003 Sep 5;308(4):956-60. doi: 10.1016/s0006-291x(03)01504-3. PMID: 12927812.
35. Pae HO, Chung HT. Heme oxygenase-1: its therapeutic roles in inflammatory diseases. Immune Netw. 2009 Feb;9(1):12-9. doi: 10.4110/in.200 9.9.1.12. Epub 2009 Feb 28. PMID: 20107533; PMCID: PMC2803295.
36. Dodson M, Anandhan A, Zhang DD, Madhavan L. An NRF2 Perspective on Stem Cells and Ageing. Front Aging. 2021 Jun 15;2:690686. doi: 10.3389/fragi.2021.690686. PMID: 36213179; PMCID: PMC9536878.
37. Li X, Li C, Zhang W, Wang Y, Qian P, Huang H. Inflammation and aging: signaling pathways and intervention therapies. Signal Transduct Target Ther. 2023 Jun 8;8(1):239. doi: 10.1038/s41392-023-01502-8. PMID: 37291105; PMCID: PMC1024 8351.
38. Shammas MA. Telomeres, lifestyle, cancer, and aging. Curr Opin Clin Nutr Metab Care. 2011 Jan;14(1):28-34. doi: 10.1097/MCO.0b013e32834 121b1. PMID: 21102320; PMCID: PMC3370421.
39. Serra V, von Zglinicki T, Lorenz M, Saretzki G. Extracellular superoxide dismutase is a major antioxidant in human fibroblasts and slows telomere shortening. J Biol Chem. 2003 Feb 28;278(9):6824-30. doi: 10.1074/jbc.M207939200. Epub 2002 Dec 9. PMID: 12475988.
40. https://pesquisa.bvsalud.org/gim/resource/en,au:%22Martins%20Neto,%20Viviana%22/sea-211132
41. Scassellati C, Galoforo AC, Bonvicini C, Esposito C, Ricevuti G. Ozone: a natural bioactive molecule with antioxidant property as potential new strategy in aging and in neurodegenerative disorders. Ageing Res Rev. 2020 Nov;63:101138. doi: 10.1016/j.arr.2020.101138. Epub 2020 Aug 15. PMID: 32810649; PMCID: PMC7428719.
42. Shehata NI, Abd-Elgawad HM, Mawsouf MN, Shaheen AA. The potential role of ozone in ameliorating the age-related biochemical changes in male rat cerebral cortex. Biogerontology. 2012 Dec;13(6):565-81. doi: 10.1007/s10522-012-9400-9. Epub 2012 Sep 22. PMID: 23001537.
43. Schmidlin CJ, Dodson MB, Madhavan L, Zhang DD. Redox regulation by NRF2 in aging and disease. Free Radic Biol Med. 2019 Apr;134:702-707. doi: 10.1016/j.freeradbiomed.2019.01.016. Epub 2019 Jan 14. PMID: 30654017; PMCID: PMC6588470.
44. Zhao X., Li Y., Lin X., Wang J., Zhao X., Xie J., Sun T., Fu Z. Ozone induces autophagy in rat chondrocytes stimulated with IL-1beta through the AMPK/mTOR signaling pathway. J.Pain Res. 2018; 11:3003–3017. [PMC free article] [PubMed] [Google Scholar] [Ref list]
45. Targeting ageing with rapamycin and its derivatives in humans: a systematic review Lee, Deborah J W et al. The Lancet Healthy Longevity, Volume 5, Issue 2, e152 - e162
46. Rowen R, Robins H, Carew K, et al. (2016) Rapid resolution of hemorrhagic fever (Ebola) in Sierra Leone with OT. African Journal of Infectious Diseases 10: 49–54.
47. Rowen RJ. Ozone and oxidation therapies as a solution to the emerging crisis in infectious disease management: a review of current knowledge and experience. Med Gas Res. 2019 Oct-Dec;9(4): 232-237. doi: 10.4103/2045-9912.273962. PMID: 31898609; PMCID: PMC7802416.
48. Jafari-Oori M, Vahedian-Azimi A, Ghorbanzadeh K, Sepahvand E, Dehi M, Ebadi A, Izadi M. Efficacy of ozone adjuvant therapy in COVID-19 patients: A meta-analysis study. Front Med (Lausanne). 2022 Nov 10;9:1037749. doi: 10.3389/fmed.2022.1037749. PMID: 36438064; PMCID: PMC9685165.
49. Brownstein, et al. A Novel Approach to Treating COVID-19 Using Nutritional and Oxidative Therapies. Science, Public Health Policy, and The Law Volume 2:4-22. July, 2020 Clinical and Translational Research
50. https://www.hopkinsmedicine.org/news/newsroom/news-releases/2018/02/study-shows-evidence-of-severe-and-lingering-symptoms-in-some-after-treatment-for-lyme-disease. Accessed 10/24
51. Ozone without Borders yearly meeting, Costa Rica 2019
52. Babior BM, Takeuchi C, Ruedi J, Gutierrez A, Wentworth P Jr. Investigating antibody-catalyzed ozone generation by human neutrophils. Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3031-4. doi: 10.1073/pnas.0530251100. Epub 2003 Feb 24. PMID: 12601145; PMCID: PMC152239.
53. Rowen RJ. OT as a primary and sole treatment for acute bacterial infection: case report. Med Gas Res. 2018 Sep 25;8(3):121-124. doi: 10.4 103/2045-9912.241078. PMID: 30319768; PMCID: PMC6178636.
54. Rowen RJ. OT in conjunction with oral antibiotics as a successful primary and sole treatment for chronic septic prosthetic joint: review and case report. Med Gas Res. 2018 Jul 3;8(2):67-71. doi: 10.4103/2045-9912.235139. PMID: 30112169; PMCID: PMC6070838.
55. "Ozone: A Chemotherapeutic Agent for the Treatment of Disease -- Experiences of a Pediatrician During the Years 1946-1964" Abstract of Paper presented at the IOA 6th Ozone World Congress (May 1983, Wash. DC)
56. Menendez S, Weiser M (2016) Advances of OT in medicine and dentistry. Palcogra, Palacio de
las Convenciones- Havana, Cuba
57. Re L, Martínez-Sánchez G, Bordicchia M, Malcangi G, Pocognoli A, Morales-Segura MA, Rothchild J, Rojas A. Is ozone pre-conditioning effect linked to Nrf2/EpRE activation pathway in vivo? A preliminary result. Eur J Pharmacol. 2014 Nov 5;742:158-62. doi: 10.1016/j.ejphar.2014.08.0 29. Epub 2014 Sep 16. PMID: 25218903.
58. Clavo B, Rodríguez-Esparragón F, Rodríguez-Abreu D, Martínez-Sánchez G, Llontop P, Aguiar-Bujanda D, Fernández-Pérez L, Santana-Rodríguez N. Modulation of Oxidative Stress by OT in the Prevention and Treatment of Chemotherapy-Induced Toxicity: Review and Prospects. Antioxidants (Basel). 2019 Nov 26;8(12):588. doi: 10.3390/antiox8120 588. PMID: 31779159; PMCID: PMC6943601.
59. Clavo B, Cánovas-Molina A, Ramallo-Fariña Y, Federico M, Rodríguez-Abreu D, Galván S, Ribeiro I, et al. Effects of Ozone Treatment on Health-Related Quality of Life and Toxicity Induced by Radiotherapy and Chemotherapy in Symptomatic Cancer Survivors. Int J Environ Res Public Health. 2023 Jan 13;20(2):1479. doi: 10.3390/ijerph20021 479. PMID: 36674232; PMCID: PMC9859304.
60. Menéndez, S., Cepero, J., & Borrego, L. (2008). OT in Cancer Treatment: State of the Art. Ozone: Science & Engineering, 30(6), 398–404. https://doi.org/10.1080/01919510802473724
61. Clavo B, Robaina F, Urrutia G, Bisshopp S, Ramallo Y, Szolna A, Caramés MA, Fiuza MD, Linertová R. OT versus surgery for lumbar disc herniation: A randomized double-blind controlled trial. Complement Ther Med. 2021 Jun;59:102724. doi: 10.1016/j.ctim.2021.102724. Epub 2021 May 5. PMID: 33964405.
62. Simon C, Le Corroller T, Pauly V, Creze M, Champsaur P, Guenoun D. Intradiscal oxygen-OT for the treatment of symptomatic lumbar disc herniation: A preliminary study. J Neuroradiol. 2022 Mar;49(2):180-186. doi: 10.1016/j.neurad.2 021.09.004. Epub 2021 Oct 8. PMID: 34634298.
63. Biazzo A, Corriero AS, Confalonieri N. Intramuscular oxygen-OT in the treatment of low back pain. Acta Biomed. 2018 Mar 27;89(1):41-46. doi: 10.23750/abm.v89i1.5315. PMID: 29633741; PMCID: PMC6357609.
64. Grangeat AM, Erario MLA. The Use of Medical Ozone in Chronic Intervertebral Disc Degeneration Can Be an Etiological and Conservative Treatment. Int J Mol Sci. 2023 Mar 31;24(7):6538. doi: 10.339 0/ijms24076538. PMID: 37047511; PMCID: PMC10 095297.
65. Raeissadat SA, Rayegani SM, Forogh B, Hassan Abadi P, Moridnia M, Rahimi Dehgolan S. Intra-articular ozone or hyaluronic acid injection: Which one is superior in patients with knee osteoarthritis? A 6-month randomized clinical trial. J Pain Res. 2018 Jan 4;11:111-117. doi: 10.2147/JPR.S 142755. PMID: 29379312; PMCID: PMC5757972.
66. Valdenassi L, Chierchia M, Pandolfi S, Bellardi D, Chirumbolo S, Franzini M. Adjunct treatment with ozone to enhance therapy of knee osteoarthritis: preliminary results. Clin Rheumatol. 2024 Jun;43 (6):2093-2101. doi: 10.1007/s10067-024-06972-x. Epub 2024 Apr 26. PMID: 38671261.
67. Fernández-Cuadros ME, Pérez-Moro OS, Albaladejo-Florín MJ, Tobar-Izquierdo MM, Magaña-Sánchez A, Jiménez-Cuevas P, Rodríguez-de-Cía J. Intra Articular Ozone Modulates Inflammation and Has Anabolic Effect on Knee Osteoarthritis: IL-6 and IGF-1 as Pro-Inflammatory and Anabolic Biomarkers. Processes. 2022; 10(1): 138. https://doi.org/10.3390/pr10010138
68. Calunga, J. L., Menéndez, S., León, R., Chang, S., Guanche, D., Balbín, A., … García, P. (2012). Application of OT in Patients with Knee Osteoarthritis. Ozone: Science & Engineering, 34(6), 469–475.
https://doi.org/10.1080/01919512.2012.719120
69. Anzolin AP, Collares DDS, Tadeu Dos Santos R, Pasqualotti A, Rossato-Grando LG, Bertol CD. Effectiveness of topical ozonated oil in severe osteoarthritis: A randomised, triple-blinded, placebo-controlled study. Complement Ther Clin Pract. 2021 May;43:101351. doi: 10.1016/j.ctcp.2021.10 1351. Epub 2021 Mar 5. PMID: 33706065.
70. Harper, D. American Academy of Stem Cell Physicians Annual Meeting, Miami Florida, October 2024. Permission by Harper for inclusion in this report.
71. Valacchi G, Bocci V. Studies on the biological effects of ozone: 10. Release of factors from ozonated human platelets. Mediators Inflamm. 1999;8(4-5):205-9. doi: 10.1080/09629359990360. PMID: 10704074; PMCID: PMC1781810.
72. León Fernández OS, Oru GT, Viebahn-Hänsler R, López Cabreja G, Serrano Espinosa I, García Fernández E. Medical ozone arrests oxidative damage progression and regulates vasoactive mediator levels in elderly patients (60-70 years) with oxidative etiology diseases. Front Physiol. 2022 Nov 3;13:1029805. doi: 10.3389/fphys.2022.1029 805. PMID: 36406985; PMCID: PMC9670171.
73. Schulz S, Ninke S, Watzer B, Nüsing RM. Ozone induces synthesis of systemic prostacyclin by cyclooxygenase-2 dependent mechanism in vivo. Biochem Pharmacol. 2012 Feb 15;83(4):506-13. doi: 10.1016/j.bcp.2011.11.025. Epub 2011 Dec 2. PMID: 22155309.
74. Stitham J, Midgett C, Martin KA, Hwa J. Prostacyclin: an inflammatory paradox. Front Pharmacol. 2011 May 13;2:24. doi: 10.3389/fphar.2 011.00024. PMID: 21687516; PMCID: PMC3108 482.
75. Tricarico G, Isakovic J, Song MS, Rustichelli F, Travagli V, Mitrecic D. Ozone influences migration and proliferation of neural stem cells in vitro. Neurosci Lett. 2020 Nov 20;739:135390. doi: 10.1016/j.neu let.2020.135390. Epub 2020 Sep 15. PMID: 3294 7004.
76. Menendez S, Weiser M. Advances of OT in Medicine and Dentistry. 2016; Havana, Cuba.
77. Sroczyński J, Antoszewski Z, Matyszczyk B, Krupa G, Rudzki H, Zbrońska H, Skowron J. Ocena kliniczna skuteczności leczenia miazdzycy zarostowej kończyn dotetniczym wstrzykiwaniem ozonu [Clinical assessment of treatment results for atherosclerotic ischemia of the lower extremities with intraarterial ozone injections]. Pol Tyg Lek. 1992 Oct 19-26;47 (42-43):964-6. Polish. PMID: 1300589.
78. Sroczyński J, Antoszewski Z, Krupa G, Zbrońska H, Matyszczak B, Rudzki H, Urbańczyk L. Niektóre parametry hemostazy po leczeniu ozonem w grupie chorych na miazdzyce zarostowa tetnic kończyn dolnych oraz w grupie chorych na cukrzyce [Some hemostatic parameters after treatment with ozone in a group of patients with obliterative atherosclerosis of the lower extremities and in a group of patients with diabetes]. Pol Tyg Lek. 1991 Sep 9-30;46(37-39):694-6. Polish. PMID: 1669134.
79. Urschel, et. al, Treatment of Arteriosclerotic Obstructive Cerebrovascular Disease with Hydrogen Peroxide.. Vascular Surgery, Vol 1, June 1967, No2, pp 77-81.
80. de Monte A, van der Zee H, Bocci V. Major ozonated autohemotherapy in chronic limb ischemia with ulcerations. J Altern Complement Med. 2005 Apr;11(2):363-7. doi: 10.1089/acm.2005.11.363. PMID: 15865505.
81. Dental Newsweek, April 27, 2016
82. Saini R. OT in dentistry: A strategic review. J Nat Sci Biol Med. 2011 Jul;2(2):151-3. doi: 10.410 3/0976-9668.92318. PMID: 22346227; PMCID: PMC3276005.
83. Domb WC. OT in dentistry. A brief review for physicians. Interv Neuroradiol. 2014 Oct 31;20 (5):632-6. doi: 10.15274/INR-2014-10083. Epub 2014 Oct 17. PMID: 25363268; PMCID: PMC4243235.
84. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=801.415
85. https://www.fda.gov/emergency-preparedness-and-response/mcm-issues/antimicrobial-resistance
86. https://www.who.int/news/item/14-06-2024-who-releases-report-on-state-of-development-of-antibacterials
87. Harvard Medical School Demonstration video: https://www.youtube.com/watch?v=plVk4NVIUh8
88. Scott JT, Sesay FR, Massaquoi TA, Idriss BR, Sahr F, Semple MG. Post-Ebola Syndrome, Sierra Leone. Emerg Infect Dis. 2016 Apr;22(4):641-6. doi: 10.3201/eid2204.151302. PMID: 26983037; PMCID: PMC4806950.
89. Rowen R and Robins H. A Plausible “Penny” Costing Effective Treatment for Corona Virus - OT. J Infect Dis Epidemiol 2020, 6:113 DOI: 10.2393 7/2474-3658/1510113 Volume 6 | Issue 2
90. Goodwin JS, Goodwin JM. The tomato effect. Rejection of highly efficacious therapies. JAMA. 1984 May 11;251(18):2387-90. doi: 10.100 1/jama.251.18.2387. PMID: 6368890.
91. “For consent to be informed, the patient must know not only of alternatives that the physician recommends, but of medically reasonable alternatives that the physician does not recommend.” Matthies v. Mastromonaco, 160 N.J. 26, 733 A.2d 456 (N.J. 1999) [available at: https://casetext.com/case/matthies-v-mastromonaco-1]
92. Chen Q, Espey MG, Krishna MC, Mitchell JB, Corpe CP, Buettner GR, Shacter E, Levine M. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13604-9. doi: 10.1073/pnas.0506390102. Epub 2005 Sep 12. PMID: 16157892; PMCID: PMC1224653.